HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Classification of childhood white matter disorders using proton MR spectroscopic imaging.

AbstractBACKGROUND AND PURPOSE:
Childhood white matter disorders often show similar MR imaging signal-intensity changes, despite different underlying pathophysiologies. The purpose of this study was to determine if proton MR spectroscopic imaging ((1)H-MRSI) may help identify tissue pathophysiology in patients with leukoencephalopathies.
MATERIALS AND METHODS:
Seventy patients (mean age, 6; range, 0.66-17 years) were prospectively examined by (1)H-MRSI; a diagnosis of leukoencephalopathy due to known genetic defects leading to lack of formation, breakdown of myelin, or loss of white matter tissue attenuation (rarefaction) was made in 47 patients. The diagnosis remained undefined (UL) in 23 patients. Patients with definite diagnoses were assigned (on the basis of known pathophysiology) to 3 groups corresponding to hypomyelination, white matter rarefaction, and demyelination. Choline (Cho), creatine (Cr), and N-acetylaspartate (NAA) signals from 6 white matter regions and their intra- and intervoxel (relative to gray matter) ratios were measured. Analysis of variance was performed by diagnosis and by pathophysiology group. Stepwise linear discriminant analysis was performed to construct a model to predict pathophysiology on the basis of (1)H-MRSI, and was applied to the UL group.
RESULTS:
Analysis of variance by diagnosis showed 3 main metabolic patterns. Analysis of variance by pathophysiology showed significant differences for Cho/NAA (P < .001), Cho/Cr (P < .004), and NAA/Cr (P < .002). Accuracy of the linear discriminant analysis model was 75%, with Cho/Cr and NAA/Cr being the best parameters for classification. On the basis of the linear discriminant analysis model, 61% of the subjects in the UL group were classified as hypomyelinating.
CONCLUSION:
(1)H-MRSI provides information on tissue pathophysiology and may, therefore, be a valuable tool in the evaluation of patients with leukoencephalopathies.
AuthorsA Bizzi, G Castelli, M Bugiani, P B Barker, E H Herskovits, U Danesi, A Erbetta, I Moroni, L Farina, G Uziel
JournalAJNR. American journal of neuroradiology (AJNR Am J Neuroradiol) Vol. 29 Issue 7 Pg. 1270-5 (Aug 2008) ISSN: 1936-959X [Electronic] United States
PMID18483189 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • FAM126A protein, human
  • Intracellular Signaling Peptides and Proteins
  • Membrane Proteins
  • Aspartic Acid
  • Lactic Acid
  • N-acetylaspartate
  • Creatine
  • Choline
Topics
  • Adrenoleukodystrophy (diagnosis, genetics, physiopathology)
  • Adult
  • Alexander Disease (diagnosis, genetics, physiopathology)
  • Aspartic Acid (analogs & derivatives, metabolism)
  • Brain (physiopathology)
  • Child
  • Child, Preschool
  • Choline (metabolism)
  • Creatine (metabolism)
  • DNA Mutational Analysis
  • Diagnosis, Differential
  • Dominance, Cerebral (physiology)
  • Female
  • Hereditary Central Nervous System Demyelinating Diseases (diagnosis, genetics, physiopathology)
  • Humans
  • Image Processing, Computer-Assisted (methods)
  • Infant
  • Intracellular Signaling Peptides and Proteins (deficiency)
  • Lactic Acid (metabolism)
  • Linear Models
  • Magnetic Resonance Imaging (methods)
  • Magnetic Resonance Spectroscopy (methods)
  • Male
  • Membrane Proteins (deficiency)
  • Mitochondrial Diseases (diagnosis, genetics, physiopathology)
  • Muscular Dystrophies (diagnosis, genetics, physiopathology)
  • Pelizaeus-Merzbacher Disease (diagnosis, genetics, physiopathology)
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: